Empagliflozin
UK Heart Failure Patient Charter Launch 2022
Living well with Heart Failure report 2022
DAPAGLIFLOZIN ACCEPTED FOR USE WITHIN NHS SCOTLAND
Legal right to 2 week review of patients with suspected heart failure (HF)
NICE Impact Report Cardiovascular Disease Management
NICE Recommends Dapagliflozin for Heart Failure
NICE in the UK recommends Dapagliflozin (FORXIGA) to treat heart failure with reduced ejection fraction for patients with or without Diabetes.
Heart failure and Covid-19 Statement
Heart Failure Marvellous Award Winners 2021 for their outstanding contribution
Alice Fearn and Jai McDowall - Music Will Live in Our Hearts
World's First Self-Management Advent Calendar Launches
European commission approves forxiga (dapagliflozin) for heart failure
Impact of COVID-19 and heart failure care in the UK
